Skip to main content
padlock icon - secure page this page is secure

Nanomedicine-Augmented Cancer-Localized Treatment by 3D Theranostic Implants

Buy Article:

$106.73 + tax (Refund Policy)

Recent advances in nanomedicine-based therapeutic platforms, which have catalyzed the generation of new therapeutic modalities for oncology, have attracted great attentions from the scientific community in recent years. However, on account of the intrinsic limitations of the low delivery efficiency for conventional cancer therapies and the unclear understanding of nano-bio interactions, oncological applications of nanomedicine for contemporary clinical translation still encounter difficulties, underscoring the need to rethink new theranosic platforms for desirable therapeutic outcome. In this review, we highlight the newly-emerged theranosic 3D implants (organic, inorganic and organic/inorganic hybrid 3D implants) based on nanomedicine for efficient localized cancer treatment, and provide an overview and deep discussion on the recent progresses in this field. The current challenges and future developments of nanomedicine-based 3D implants on combating cancer are also discussed for their further potential clinical translations. It is highly believed that these constructed multifunctional 3D theranostic implants will pave a new way for the efficient cancer therapy based on their high therapeutic outcome and reduced side effects.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Review Article

Publication date: August 1, 2017

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more